PNC Financial Services Group’s Tyra Biosciences TYRA Stock Holding History

PNC Financial Services Group’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.64K	Sell	208 -15	-7%	-$496	﹤0.01%	4283
2026 Q1	$8.54K	Buy	223 +15	+7%	+$486	﹤0.01%	4024
2025 Q4	$5.47K	Hold	208	–	–	﹤0.01%	4200
2025 Q3	$2.91K	Buy	208 +150	+259%	+$1.71K	﹤0.01%	4399
2025 Q2	$555	Hold	58	–	–	﹤0.01%	4668
2025 Q1	$539	Hold	58	–	–	﹤0.01%	4629
2024 Q4	$806	Hold	58	–	–	﹤0.01%	4467
2024 Q3	$1.36K	Hold	58	–	–	﹤0.01%	4382
2024 Q2	$927	Hold	58	–	–	﹤0.01%	4442
2024 Q1	$951	Hold	58	–	–	﹤0.01%	4371
2023 Q4	$803	Hold	58	–	–	﹤0.01%	4348
2023 Q3	$799	Hold	58	–	–	﹤0.01%	4416
2023 Q2	$988	Hold	58	–	–	﹤0.01%	4514
2023 Q1	$932	Hold	58	–	–	﹤0.01%	4450
2022 Q4	$441	Hold	58	–	–	﹤0.01%	4545
2022 Q3	$1K	Hold	58	–	–	﹤0.01%	4352
2022 Q2	$0	Buy	+58	New	+$462	﹤0.01%	4719

Other funds holding TYRA

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

APMC

Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

PNC Financial Services Group's TYRA Position: Q2 2026 in Review

PNC Financial Services Group reduced its Tyra Biosciences (TYRA) stake by 6.7% in Q2 2026, selling an estimated $496 and leaving 208 shares worth $6.64K. The position accounts for ﹤0.01% of the portfolio, ranked #4283.

PNC Financial Services Group first reported a position in TYRA in Q2 2022 and has held it in 17 quarters since. The position peaked at $8.54K in Q1 2026. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

PNC Financial Services Group held 208 shares of Tyra Biosciences worth $6.64K as of Q2 2026.
PNC Financial Services Group sold 15 Tyra Biosciences shares in Q2 2026, an estimated $496.
Tyra Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4283 holding.
PNC Financial Services Group first reported a position in Tyra Biosciences in Q2 2022 and has held it in 17 quarters since.
PNC Financial Services Group's Tyra Biosciences position peaked at $8.54K in Q1 2026.
168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.